Stories
Prime Therapeutics lands No. 3 spot on Minneapolis/St. Paul Business Journal’s 2020 Top 100 Private Companies List
Prime ranked third-largest in state by revenue
September 4, 2020
For a third consecutive year, The Minneapolis/St. Paul Business Journal placed Prime at No. 3 on its 2020 Top 100 Private Companies List. Once again, Prime shares the top three with Cargill and CHS.
The annual list ranks companies by revenue. To qualify for the ranking, a company must have headquarters in Minnesota, be a for-profit operation and not issue stock to the public.
The full Top 100 Private Companies List is available now online and will publish in the Minneapolis/St. Paul Business Journal’s annual Book of Lists later this year.
Related news
Stories
July 22, 2024
Introducing the latest issue of our medical and pharmacy benefit management report
The summer 2024 issue of the Magellan Rx Report provides insights on the industry’s most groundbreaking managed care solutions in some of the most complex areas of health care
Stories
July 18, 2024
Specialty drug trend forecasted to drop for employer groups, clinical experts say
Introduction of Humira® and Stelara® biosimilars contribute to continued decline in the autoimmune – anti-inflammatory trend
Stories
July 16, 2024
Prime/Magellan Rx earns top score on the Disability Equality Index
For the second consecutive year, Prime Therapeutics/Magellan Rx Management received a score of 100 on the Disability Equality Index®, which benchmarks disability workplace inclusion